|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.385 USD | +0.21% |
|
+2.80% | +32.50% |
| May. 13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| May. 13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Quotes 5-day view: Protalix BioTherapeutics, Inc.
Delayed Quote NYSE
| 2026-07-02 | 2026-07-06 | 2026-07-07 | 2026-07-08 | 2026-07-09 | |
|---|---|---|---|---|---|
| Last | $2.320 | $2.300 | $2.360 | $2.380 | $2.385 |
| Volume | 472,793 | 366,793 | 696,492 | 584,301 | 177,270 |
| Change | +0.87% | -0.86% | +2.61% | +0.85% | +0.21% |
| Opening | $2.300 | $2.310 | $2.310 | $2.350 | $2.390 |
| High | $2.355 | $2.350 | $2.385 | $2.410 | $2.435 |
| Low | $2.270 | $2.295 | $2.256 | $2.345 | $2.370 |
Performance
| 1 day | -0.21% | ||
| 1 week | +2.80% | ||
| Current month | +2.36% | ||
| 1 month | +20.45% | ||
| 3 months | +4.61% | ||
| 6 months | +15.22% | ||
| Current year | +32.50% | ||
| 1 year | +55.88% | ||
| 3 years | +28.23% | ||
| 5 years | +37.86% | ||
| 10 years | -62.44% |
Volumes
marketsDaily volume
177,270
Estimated daily volume
504,944
Avg. Volume 20 sessions
789,098
Daily volume ratio
0.64
Avg. Volume 20 sessions USD
1,881,998.73
Record volume 1
191,289,000
Record volume 2
19,414,390
Record volume 3
12,716,823
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
191,760,507
Net sales (USD)
52,744,000
Number of employees
226
Sales / Employee (USD)
233,381
Free-Float
96.12 %
Free-Float capitalization (USD)
184,324,426
Average Daily Capital Traded
0.98%
Indicators
Moving average 5 days
2.322
Moving average 20 days
2.173
Moving average 50 days
2.091
Moving average 100 days
2.32
Price spread / (MMA5)
-2.64%
Price spread / (MMA20)
-8.89%
Price spread / (MMA50)
-12.34%
Price spread / (MMA100)
-2.70%
STIM
RSI 9 days
69.2
RSI 14 days
65.4
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | +2.80% | +55.88% | +28.23% | 192M | |
| -1.14% | -0.17% | +53.99% | +167.41% | 1,084B | |
| -1.64% | -1.18% | +66.32% | +62.96% | 634B | |
| -1.01% | -3.80% | +31.75% | +86.74% | 447B | |
| +0.18% | -1.76% | +29.04% | +26.48% | 330B | |
| -6.22% | -8.14% | +28.87% | +31.18% | 295B | |
| -1.27% | -2.91% | +27.42% | +44.91% | 285B | |
| -0.93% | -3.57% | -27.74% | -39.70% | 218B | |
| -1.64% | -2.83% | +22.60% | +61.77% | 199B | |
| -1.60% | +1.98% | +18.22% | +76.87% | 169B | |
| Average | -1.56% | +2.40% | +30.64% | +54.68% | 366.01B | |
| Weighted average by Cap. | -1.56% | +2.48% | +38.85% | +84.00% |
Historical Quotes: Protalix BioTherapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
a4d05fdfe0f958e3dd7b837e.d81snRuADOUUzcTOQYZchA9nQtmukVmJ7ITPLaiVLd4.DZw673zwIdRRv6avdswpwj0-Me_6ojTd2La4au7bZ4Ql-hXkS9dlknb7pw
| Date | Price | Volume | Total |
|---|---|---|---|
| 11:45:54 am | 2.385 | 100 | 138,592 |
| 11:45:43 am | 2.385 | 1,800 | 138,492 |
| 11:44:44 am | 2.385 | 100 | 136,692 |
| 11:44:44 am | 2.385 | 194 | 136,592 |
| 11:44:44 am | 2.380 | 100 | 136,398 |
| 11:44:44 am | 2.380 | 100 | 136,298 |
| 11:44:44 am | 2.380 | 100 | 136,198 |
| 11:40:36 am | 2.371 | 100 | 136,098 |
| 11:40:19 am | 2.375 | 151 | 135,998 |
| 11:38:07 am | 2.380 | 100 | 135,847 |
Course Extremes
| 1 week | 2.26 |  | 2.44 |
| 1 month | 1.96 | | 2.44 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.36 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
Monthly variations
Annual variations
| 2026 | +32.22% | ||
| 2025 | -4.26% | ||
| 2024 | +5.62% | ||
| 2023 | +29.93% | ||
| 2022 | +64.72% | ||
| 2021 | -77.09% | ||
| 2020 | +10.67% | ||
| 2019 | +5.47% | ||
| 2018 | -52.96% | ||
| 2017 | +48.58% | ||
| 2016 | -56.37% | ||
| 2015 | -44.57% | ||
| 2014 | -52.70% | ||
| 2013 | -25.05% | ||
| 2012 | +5.27% | ||
| 2011 | -50.60% | ||
| 2010 | +50.76% | ||
| 2009 | +259.78% | ||
| 2008 | -45.88% | ||
| 2007 | -87.48% |
- Stock Market
- Stocks
- PLX Stock
- Quotes Protalix BioTherapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
